Abbott Laboratories 2012 Annual Report Download - page 67

On the
cover:
Table of Contents
1 Letter to Shareholders
6 Abbott: a Well Balanced Mix of Businesses
14 Abbott: Innovation Highlights
16 AbbVie: a Unique Biopharmaceutical Company
22 AbbVie: Pipeline Highlights
24 Financial Report
25 Consolidated Financial Statements and Notes
46 Management Report on Internal Control
Over Financial Reporting
47 Reports of Independent Registered
Public Accounting Firm
48 Financial Instruments and Risk Management
49 Financial Review
63 Summary of Selected Financial Data
64 Directors and Corporate Of cers
65 Shareholder and Corporate Information
Abbott brings a unique mix of
diversi ed, leading healthcare
businesses together in one
growth-focused, large-cap medical
products company. Abbott’s
ongoing success in Diagnostics,
Medical Devices, Nutritionals and
Branded Generic Pharmaceuticals
will be built on broad and balanced
portfolios, precisely targeted to
patient needs in a variety of growth
markets around the world.
As an infant, 18-month-old Beeri Noyman suffered
with frequent stomach upsets. Then his mother,
Meli, started feeding him Similac Comfort. Called
Similac Total Comfort in most markets around the
world, this is a formulation speci cally designed
for persistent feeding issues. Soon, Beeri had
fewer feeding issues, and, more importantly,
was a happy baby.
Similac Comfort
Beeri and Meli Noyman
Tel Aviv, Israel
Some statements in this annual report may be forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995.
Abbott cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from
those indicated in the forward-looking statements. Economic, competitive, governmental, technological and other factors that may affect Abbott’s
operations are discussed in Item 1A, “Risk Factors,” in our Securities and Exchange Commission 2012 Form 10-K and are incorporated by reference.
We undertake no obligation to release publicly any revisions to forward-looking statements as the result of subsequent events or developments.
Abbott trademarks and products in-licensed by Abbott are shown in italics in the text of this report. The illustrations on pages 22 and 23 are artist’s renditions.
© 2013 Abbott Laboratories
The Abbott 2012 Annual Report was printed with the use of renewable wind power resulting in nearly zero carbon
emissions, keeping 18,552 pounds of CO2 from the atmosphere. This amount of wind-generated electricity is
equivalent to 16,096 miles not driven in an automobile or 1,262 trees planted. The Abbott Annual Report cover
and text is printed on recycled paper that contains a minimum of 10% post-consumer (PCW) fiber and the
financial pages on 30% post-consumer (PCW) fiber.
Stock Listing
The ticker symbol for Abbott’s common
stock is ABT. The principal market for
Abbott’s common shares is the New York
Stock Exchange. Shares are also listed on
the Chicago Stock Exchange and traded on
various regional and electronic exchanges.
Outside the United States, Abbott’s shares
are listed on the London Stock Exchange
and the Swiss Stock Exchange.
Quarterly Dividend Dates
Dividends are expected to be declared and
paid on the following schedule in 2013,
pending approval by the board of directors:
Quarter Declared Record Paid
First 2/15 4/15 5/15
Second 6/14 7/15 8/15
Third 9/13 10/15 11/15
Fourth 12/13 1/15/14 2/14/14
Tax Information for Shareholders
Abbott is an Illinois High Impact
Business and is located in a U.S. federal
Foreign Trade Sub-Zone (Sub-Zone 22F).
Dividends may be eligible for a subtraction
from base income for Illinois income
tax purposes.
If you have any questions, please contact
your tax advisor.
Dividend Reinvestment Plan
The Abbott Dividend Reinvestment
Plan offers registered shareholders
an opportunity to purchase additional
shares, commission-free, through
automatic dividend reinvestment and/or
optional cash investments. Interested
persons may contact the transfer
agent, call Abbott’s Investor Newsline
or write Abbott Shareholder Services.
Dividend Direct Deposit
Shareholders may have quarterly dividends
deposited directly into a checking or
savings account at any financial institution
that participates in the Automated Clearing
House system. For more information,
please contact the transfer agent, call
the Investor Newsline or write Abbott
Shareholder Services.
Direct Registration System
In August 2008, Abbott implemented
a Direct Registration System (DRS) for
all registered shareholder transactions.
Shareholders will be sent a statement in
lieu of a physical stock certificate for
Abbott Laboratories stock. Please contact
the transfer agent with any questions.
Annual Meeting
The annual meeting of shareholders will
be held at 9 a.m. on Friday, April 26, 2013,
at Abbott’s corporate headquarters.
Questions regarding the annual meeting
may be directed to the Corporate Secretary.
A copy of Abbott’s 2012 Form 10-K Annual
Report, as filed with the Securities and
Exchange Commission, is available on
the Abbott Web site at www.abbott.com
or by contacting the Investor Newsline.
CEO and CFO Certifications
In 2012, Abbott’s chief executive officer
(CEO) provided to the New York Stock
Exchange the annual CEO certification
regarding Abbott’s compliance with the
New York Stock Exchange’s corporate
governance listing standards. In addition,
Abbott’s CEO and chief financial officer
filed with the U.S. Securities and Exchange
Commission all required certifications
regarding the quality of Abbott’s public
disclosures in its fiscal 2012 reports.
Investor Newsline
[phone]
Investor Relations
Dept. 362, AP6D2
Shareholder Services
Dept. 312, AP6D2
Corporate Secretary
Dept. 364, AP6D2
Abbott
100 Abbott Park Road
Abbott Park, IL 60064-6400 U.S.A.
(847) 937-610 0
Website
www.abbott.com
Abbott Online Annual Report
www.abbott.com/annualreport
Global Citizenship Report
www.abbott.com/citizenship
Transfer Agent and Registrar
Computershare
P.O. Box 43078
Providence, RI 02940-3078
[phone]
www.computershare.com
Shareholder Information
Shareholders with questions about their
accounts may contact the transfer agent,
call the Investor Newsline or write Abbott
Shareholder Services.
Individuals who would like to receive
additional information or have questions
regarding Abbott’s business activities
may call the Investor Newsline, write Abbott
Investor Relations or visit Abbott’s Web site.
Shareholder and Corporate Information